Induction of Migraine Aura With Cilostazol

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

In a double blind placebo-controlled cross-over study the effect of cilostazol on aura induction and endothelial response is tested in patient with migraine with aura.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Herlev Hospital
• Treatments: Cilostazol

Criteria

Inclusion Criteria:

• Migraine with aura

• Minimum of 2 attacks/year

Exclusion Criteria:

• Chronic tension type headache

• Cardiac arrhythmias